Multiple Sclerosis
Learn about Multiple Sclerosis, its reported features, relevant specialists, and questions to discuss at a medical consultation.
Also known as: Disseminated sclerosis; MS
The sources compiled here do not cover: prevention, prevalence. Ask the treating doctor about these.
What is multiple sclerosis?
From: MedlinePlus, National Library of Medicine
Multiple sclerosis (MS) is a disease that affects your brain and spinal cord, also called the central nervous system. MS damages myelin, the protective coating around your nerve cells. Myelin helps nerves send messages quickly. When it's damaged, messages between your brain and body slow down or get blocked. This leads to MS symptoms.
What are the types of multiple sclerosis?
From: MedlinePlus, National Library of Medicine
Not everyone with MS has the same experience. MS is grouped into types based on how the disease changes over time. Types of MS include:
- Relapsing-remitting MS. The most common type. People have flare-ups of new or worsening symptoms (relapses), followed by periods of recovery with few or no symptoms.
- Secondary-progressive MS. Some people with relapse-remitting MS later develop this type. Symptoms slowly get worse over time, with fewer or no recovery periods.
- Primary-progressive MS. Symptoms slowly worsen from the start, without clear relapses or periods of recovery.
- Clinically isolated syndrome. A single episode of symptoms like MS that last at least 24 hours. It may be an early sign of MS, but not everyone develops MS afterward.
- Radiologically isolated syndrome. Brain changes that look like MS show up on an MRI, but the person has no symptoms. Some people go on to develop MS symptoms, and some do not.
What causes multiple sclerosis?
From: MedlinePlus, National Library of Medicine
No one knows the exact cause of MS. Many believe it is an autoimmune disease. This means your immune system mistakenly attacks healthy cells. In MS, the immune system attacks myelin.
Several factors may work together to raise the risk of MS, including:
- A previous infection with Epstein-Barr virus, which is the most common cause of mononucleosis (mono).
- Environmental influences, such as smoking, little sun exposure, or low levels of vitamin D.
- Genetic factors, such as certain genes. These are parts of DNA in your cells that are passed down from your parents. Having certain genes may increase your risk of MS, but not everyone with these genes gets the disease.
- A family history of MS, meaning having a close relative who has been diagnosed with MS.
- Your sex, since MS is two to three times more common in women than in men.
- Your age, since MS most often begins between the ages of 20 and 40.
What are the symptoms of multiple sclerosis?
From: MedlinePlus, National Library of Medicine
MS symptoms vary from person to person. Some people have mild symptoms, while others may have more serious problems. Symptoms depend on which nerves are affected. Common symptoms may include:
- Blurry or double vision, or eye pain (often due to optic neuritis)
- Trouble with bladder control
- Muscle weakness
- Muscle stiffness or spasms
- Trouble with coordination, walking, or balance
- Numbness, tingling, or a "pins and needles" feeling
- Thinking or memory problems
- Fatigue
- Dizziness or vertigo
- Mood changes
How is multiple sclerosis diagnosed?
From: MedlinePlus, National Library of Medicine
There is no specific test for MS. Your health care provider may use several tools to make a diagnosis, including:
- A review of your health history and symptoms
- A physical exam and neurological exam, which checks your reflexes, strength, and senses
- An MRI scan to look for damage in the brain and spinal cord
- Blood tests to rule out other conditions
- A lumbar puncture (spinal tap) to check fluid around your brain and spinal cord for signs of MS
What are the treatments for multiple sclerosis?
From: MedlinePlus, National Library of Medicine
There is no cure for MS, but treatment can help manage symptoms and slow the disease. Treatments may include:
- Disease-modifying medicines. These help slow MS and reduce relapses. They may be taken as pills, injections, or infusions.
- Medicines for symptoms, such as muscle stiffness or pain.
- Physical and occupational therapy help with movement, strength, and daily activities.
Living with MS can affect how you feel emotionally. To help you cope with these changes, try to reduce stress, connect with supportive people, eat healthy foods, and stay as active as you comfortably can.
Genetic causes described in the linked summary
From: MedlinePlus Genetics
MS is likely caused by a combination of genetic, environmental, and lifestyle factors.
In people with MS, the immune system attacks the body's own tissues and organs. This abnormal immune response triggers inflammation, damaging the myelin sheath that protects the nerves in the brain and spinal cord. The damage impairs the communication between these nerve cells and the rest of the body. Over time, nerve cells that lack myelin are more prone to damage and may begin to die off, creating larger areas of injury in the nervous system.
Common genetic changes in or near hundreds of genes likely contribute to a person's risk of developing MS. Many of these genes provide instructions for making proteins that play a role in the immune system.
Changes in several genes within the human leukocyte antigen (HLA) complex have been associated with MS. These changes produce different versions of many HLA genes. Different versions of a gene are called alleles. Alleles of some HLA genes have been associated with an increased risk of developing MS, while others seem to protect against it.
HLA complex genes help the immune system distinguish between the body's own proteins and proteins made by foreign invaders, such as viruses and bacteria. Each HLA gene has many possible alleles, allowing each person's immune system to respond to a wide range of foreign proteins. The most well-established genetic risk factor for developing MS is an allele of the HLA-DRB1 gene called HLA-DRB1*15:01. The HLA-DRB1 gene provides instructions for making a protein that initiates an immune response. Researchers are working to learn exactly how the HLA-DRB1*15:01 allele interacts with other alleles to influence the risk of developing MS.
Certain environmental and lifestyle factors, such as Epstein-Barr virus infections, a lack of exposure to sunlight, vitamin D deficiency, obesity, smoking, and exposure to secondhand smoke, are believed to increase the risk of developing MS. These factors have an especially strong influence on the risk of developing MS when they are present during childhood or adolescence.
Inheritance described in the linked summary
From: MedlinePlus Genetics
MS does not follow a clear inheritance pattern, since genetic, lifestyle, and environmental factors are all likely involved in the development of this disease. However, the risk of developing MS is higher for close family members of affected individuals than for the general population.
Which doctor should you see?
The suggested department for discussing Multiple Sclerosis is Neurology, with a neurologist as the relevant type of clinician. General physician / Family Medicine; paediatrician for children. Referral depends on symptoms.
Additional services that may be relevant, depending on the findings, include: Clinical Genetics.
This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.
How to prepare for an assessment
Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.
Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.
- Which nervous-system findings help explain the symptoms?
- Would an assessment of walking, communication or daily function be helpful?
- Are rehabilitation or other specialist services relevant?
Treatment discussions and follow-up
Where the source describes treatments, these are an overview of possible care, not a prescription for an individual. Ask which option applies to the confirmed diagnosis, what benefit is expected, what adverse effects to watch for and how progress will be assessed. Availability, approvals and local practice can differ from the country described in the source.
Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.
The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.
When to seek emergency help
Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.
This condition is usually assessed by a neurologist. Every profile shows the doctor’s registration and what has been checked.
Sources
- MedlinePlus, National Library of Medicine — Multiple Sclerosis — Public-domain health-topic summary
- MedlinePlus Genetics — Multiple sclerosis — Public-domain Genetics summary
- Government of India — Emergency Response Support System — Official reference for India emergency number
Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.
General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1628.